Home/Filings/4/0001839882-25-011945
4//SEC Filing

Fogarty Siobhan 4

Accession 0001839882-25-011945

CIK 0001430306other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 6:42 PM ET

Size

7.9 KB

Accession

0001839882-25-011945

Insider Transaction Report

Form 4
Period: 2025-02-25
Fogarty Siobhan
Chief Technology Officer
Transactions
  • Award

    Stock Option

    2025-02-25+13,50013,500 total
    Exercise: $8.05From: 2026-02-25Exp: 2035-02-25Common Stock (13,500 underlying)
  • Award

    Stock Option

    2025-02-25+13,50013,500 total
    Exercise: $10.06From: 2026-02-25Exp: 2035-02-25Common Stock (13,500 underlying)
Footnotes (2)
  • [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
  • [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1
  • filerCIK 0002055825

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:42 PM ET
Size
7.9 KB